Cargando…
Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels
This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior.
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644257/ https://www.ncbi.nlm.nih.gov/pubmed/36346635 http://dx.doi.org/10.1001/jamanetworkopen.2022.40513 |